Medpace’s 20% Crash: Why the Earnings Beat Couldn’t Save the Stock
Ticker: MEDP | Event: Q1 2026 earnings release, April 22, 2026 | Stock reaction: ~20% drop TL;DR Medpace posted Q1 2026 revenue of $706.6 million, up 26.5% year-over-year, yet the stock dropped roughly 20% after hours because forward indicators collapsed. The net book-to-bill ratio fell to 0.88, the weakest reading in more than a year […]
